top of page

Resources

CCSS Statement on FDA Cannabinoid Pathway Framework Announcement

CCSS looks forward to working with Congress and FDA on a science-based approach to regulate non-drug CBD products, protecting consumer safety must be paramount.


Click here to view the PDF.


Comments


The Collaborative for Cannabinoid Science and Safety | Privacy Policy

© 2023 Collaborative for Cannabinoid Science and Safety. All rights Reserved.

bottom of page